You are here: Industry Insights > API

News List

Teva Announces Recall americanpharmaceuticalreview
November 29, 2018
Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan.....
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network pharmafocusasia
November 28, 2018
Cambrex Corporation, a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced......
Cambrex Buys Avista for $252M contractpharma
November 27, 2018
Cambrex has entered into a definitive agreement to acquire Avista Pharma Solutions for roughly $252 million. Avista is a portfolio company of Ampersand Capital Partners.
ASIT Biotech Adds GMP Manufacturing Unit contractpharma
November 27, 2018
ASIT biotech has installed and qualified a clean room with the equipment to produce, in compliance with GMP requirements, the API for the Phase I/II studies in house dust mite and peanut allergies treatment.
Acquisition boosts Cambrex's early-stage development capabilities cphi-online
November 27, 2018
Avista is a portfolio company of Ampersand Capital Partners, a leading healthcare-focused private equity firm. With this acquisition, Cambrex will enter the large and growing market
Piramal Pharma Solutions unveils cGMP kilo lab suite for API expressbpd
November 22, 2018
The suite in Chennai will formally open on December 1, 2018
Bedrocan becomes world’s first GMP cannabis producer cphi-online
November 15, 2018
Following a rigorous inspection by the Dutch Health Care Inspectorate, Bedrocan in the Netherlands has become the world’s first producer of medicinal cannabis to be compliant...
GlaxoSmithKline expands API production for COPD inhalers as Advair sales wither fiercepharma
October 24, 2018
Even with looming generic competition expected to take a big bite out of sales of its blockbuster Advair, respiratory drugs remain key to GlaxoSmithKline, and it continues to plow money into their production.
WuXi's API manufacturing passes FDA inspection biospectrumasia
October 23, 2018
WuXiPharmaTech passed inspection for API manufacturing baseSingapore:China-based WuXiPharmaTech, pharmaceutical, biotech
Govt aims to raise API production to cut Chinese dependence expressbpd
October 11, 2018
The government is working on a road map to increase production of bulk drugs in the country with a view to reduce import

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page